IMH doctors get trained in new therapy
Updated:
Updated:
rTMS is a method of therapy for persons with medication-resistant hallucinations, schizophrenia, depression, and nicotine-dependence
Share Article
rTMS is a method of therapy for persons with medication-resistant hallucinations, schizophrenia, depression, and nicotine-dependence A year after purchasing a rTMS (Repetitive Transcranial Magnetic Stimulation) machine, the Institute of Mental Health (IMH) (IMH) is all set to put it to use after a group of postgraduates and faculty members received hands-on training in the therapy.
K. Muralidharan, medical superintendent and professor of psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, provided hands-on training for postgraduates and faculty members over two days.
Affordable, accessible SII vaccine likely to be state’s anti-Covid shot December 10, 2020, 3:31 PM IST
Tamil Nadu recently released the action plan for preparatory activities for Covid-19 vaccine such as identifying frontline workers and assessing cold chain space. Tamil Nadu Medical Services Corporation managing director P Umanath and director of public health Dr T S Selvavinayagam speak to TOI about the state’s preparedness. Excerpts:
What kind of vaccine are we expecting for Tamil Nadu?
Umanath: We have some idea about the vaccine we are likely to receive. It is unlikely that we will use an mRNA vaccine manufactured by Pfizer or Moderna for many reasons. First, they have several pre-orders to fulfil. Second, they may be too expensive for us compared to other vaccines that are in the pipeline. Also, we may not be able to fulfil their cold storage conditions. Whereas, the other vaccines like the desi Serum Institute of India vaccine can be more availab